51. Solid inclusion complexes of oleanolic acid with amino-appended β-cyclodextrins (ACDs): Preparation, characterization, water solubility and anticancer activity
- Author
-
Kai Gao, Bo Yang, Jihong Zhang, Zhikuan Yang, Ying Liu, Raomei Niu, Xiali Liao, and Yufeng Ren
- Subjects
Magnetic Resonance Spectroscopy ,Bioengineering ,Antineoplastic Agents ,Apoptosis ,02 engineering and technology ,β cyclodextrins ,010402 general chemistry ,01 natural sciences ,Biomaterials ,chemistry.chemical_compound ,X-Ray Diffraction ,Spectroscopy, Fourier Transform Infrared ,Zeta potential ,Organic chemistry ,Humans ,Oleanolic Acid ,Oleanolic acid ,Aqueous solution ,Calorimetry, Differential Scanning ,Chemistry ,beta-Cyclodextrins ,Water ,Hep G2 Cells ,021001 nanoscience & nanotechnology ,HCT116 Cells ,In vitro ,0104 chemical sciences ,Bioavailability ,Solubility ,Mechanics of Materials ,Cancer cell ,Microscopy, Electron, Scanning ,0210 nano-technology ,Two-dimensional nuclear magnetic resonance spectroscopy ,HT29 Cells - Abstract
Oleanolic acid (OA) is a pentacyclic triterpenoid acid of natural abundance in plants which possesses important biological activities. However, its medicinal applications were severely impeded by the poor water solubility and resultant low bioavailability and potency. In this work, studies on solid inclusion complexes of OA with a series of amino-appended β-cyclodextrins (ACDs) were conducted in order to address this issue. These complexes were prepared by suspension method and were well characterized by NMR, SEM, XRD, TG, DSC and Zeta potential measurement. The 2:1 inclusion mode of ACDs/OA complexes was elucidated by elaborate 2D NMR (ROESY). Besides, water solubility of OA was dramatically promoted by inclusion complexation with ACDs. Moreover, in vitro anticancer activities of OA against human cancer cell lines HepG2, HT29 and HCT116 were significantly enhanced after formation of inclusion complexes, while the apoptotic response results indicated their induction of apoptosis of cancer cells. This could provide a novel approach to development of novel pharmaceutical formulations of OA.
- Published
- 2016